Global Pneumococcal Vaccines Market

Global Pneumococcal Vaccines Market Research Report 2021

Global Pneumococcal Vaccines Market

Global Pneumococcal Vaccines Market Research Report 2021

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Pneumococcal Vaccines Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Pneumococcal Vaccines Market Overview:

Global Pneumococcal Vaccines Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Pneumococcal Vaccines involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Pneumococcal Vaccines Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Pneumococcal Vaccines market in 2020.

Global Pneumococcal Vaccines Market Segmentation

By Type, Pneumococcal Vaccines market has been segmented into:

PPSV 23

PCV 7/13

PCV 10

By Application, Pneumococcal Vaccines market has been segmented into:

For Infants

For Children (2-10)

For Person (10-64)

For The Old (≥65)

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Pneumococcal Vaccines market are:

Pfizer

Sanofi

GSK

Merck

Eli Lilly

AstraZeneca

Abera

S K Chemicals

Beijing Minhai Biotechnology

Baxter

Biken

Celgene Corporation

Panacea Biotec

Serum Institute of India

Genentech

Genocea Biosciences

ImmunoBiology

Lupin

Nuron Biotech

Biogen

Valneva Austria

Sinovac

1. Market Overview of Pneumococcal Vaccines

1.1 Pneumococcal Vaccines Market Overview

1.1.1 Pneumococcal Vaccines Product Scope

1.1.2 Market Status and Outlook

1.2 Pneumococcal Vaccines Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Pneumococcal Vaccines Historic Market Size by Regions (2015-2020)

1.4 Pneumococcal Vaccines Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Pneumococcal Vaccines Sales Market by Type (2015-2026)

2.1 Global Pneumococcal Vaccines Historic Market Size by Type (2015-2020)

2.2 Global Pneumococcal Vaccines Forecasted Market Size by Type (2021-2026)

2.3 PPSV 23

2.4 PCV 7/13

2.5 PCV 10

3. Covid-19 Impact Pneumococcal Vaccines Sales Market by Application (2015-2026)

3.1 Global Pneumococcal Vaccines Historic Market Size by Application (2015-2020)

3.2 Global Pneumococcal Vaccines Forecasted Market Size by Application (2021-2026)

3.3 For Infants

3.4 For Children (2-10)

3.5 For Person (10-64)

3.6 For The Old (≥65)

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Pneumococcal Vaccines Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Pneumococcal Vaccines Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Pneumococcal Vaccines Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Pneumococcal Vaccines Business

5.1 Pfizer

5.1.1 Pfizer Company Profile

5.1.2 Pfizer Pneumococcal Vaccines Product Specification

5.1.3 Pfizer Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Sanofi

5.2.1 Sanofi Company Profile

5.2.2 Sanofi Pneumococcal Vaccines Product Specification

5.2.3 Sanofi Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 GSK

5.3.1 GSK Company Profile

5.3.2 GSK Pneumococcal Vaccines Product Specification

5.3.3 GSK Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Merck

5.4.1 Merck Company Profile

5.4.2 Merck Pneumococcal Vaccines Product Specification

5.4.3 Merck Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 Eli Lilly

5.5.1 Eli Lilly Company Profile

5.5.2 Eli Lilly Pneumococcal Vaccines Product Specification

5.5.3 Eli Lilly Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 AstraZeneca

5.6.1 AstraZeneca Company Profile

5.6.2 AstraZeneca Pneumococcal Vaccines Product Specification

5.6.3 AstraZeneca Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Abera

5.7.1 Abera Company Profile

5.7.2 Abera Pneumococcal Vaccines Product Specification

5.7.3 Abera Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 S K Chemicals

5.8.1 S K Chemicals Company Profile

5.8.2 S K Chemicals Pneumococcal Vaccines Product Specification

5.8.3 S K Chemicals Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 Beijing Minhai Biotechnology

5.9.1 Beijing Minhai Biotechnology Company Profile

5.9.2 Beijing Minhai Biotechnology Pneumococcal Vaccines Product Specification

5.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 Baxter

5.10.1 Baxter Company Profile

5.10.2 Baxter Pneumococcal Vaccines Product Specification

5.10.3 Baxter Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 Biken

5.11.1 Biken Company Profile

5.11.2 Biken Pneumococcal Vaccines Product Specification

5.11.3 Biken Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 Celgene Corporation

5.12.1 Celgene Corporation Company Profile

5.12.2 Celgene Corporation Pneumococcal Vaccines Product Specification

5.12.3 Celgene Corporation Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 Panacea Biotec

5.13.1 Panacea Biotec Company Profile

5.13.2 Panacea Biotec Pneumococcal Vaccines Product Specification

5.13.3 Panacea Biotec Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.14 Serum Institute of India

5.14.1 Serum Institute of India Company Profile

5.14.2 Serum Institute of India Pneumococcal Vaccines Product Specification

5.14.3 Serum Institute of India Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.15 Genentech

5.15.1 Genentech Company Profile

5.15.2 Genentech Pneumococcal Vaccines Product Specification

5.15.3 Genentech Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.16 Genocea Biosciences

5.16.1 Genocea Biosciences Company Profile

5.16.2 Genocea Biosciences Pneumococcal Vaccines Product Specification

5.16.3 Genocea Biosciences Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.17 ImmunoBiology

5.17.1 ImmunoBiology Company Profile

5.17.2 ImmunoBiology Pneumococcal Vaccines Product Specification

5.17.3 ImmunoBiology Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.18 Lupin

5.18.1 Lupin Company Profile

5.18.2 Lupin Pneumococcal Vaccines Product Specification

5.18.3 Lupin Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.19 Nuron Biotech

5.19.1 Nuron Biotech Company Profile

5.19.2 Nuron Biotech Pneumococcal Vaccines Product Specification

5.19.3 Nuron Biotech Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.20 Biogen

5.20.1 Biogen Company Profile

5.20.2 Biogen Pneumococcal Vaccines Product Specification

5.20.3 Biogen Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.21 Valneva Austria

5.21.1 Valneva Austria Company Profile

5.21.2 Valneva Austria Pneumococcal Vaccines Product Specification

5.21.3 Valneva Austria Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.22 Sinovac

5.22.1 Sinovac Company Profile

5.22.2 Sinovac Pneumococcal Vaccines Product Specification

5.22.3 Sinovac Pneumococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Pneumococcal Vaccines Market Size (2015-2026)

6.2 North America Pneumococcal Vaccines Key Players in North America (2015-2020)

6.3 North America Pneumococcal Vaccines Market Size by Type (2015-2020)

6.4 North America Pneumococcal Vaccines Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Pneumococcal Vaccines Market Size (2015-2026)

7.2 East Asia Pneumococcal Vaccines Key Players in North America (2015-2020)

7.3 East Asia Pneumococcal Vaccines Market Size by Type (2015-2020)

7.4 East Asia Pneumococcal Vaccines Market Size by Application (2015-2020)

8. Europe

8.1 Europe Pneumococcal Vaccines Market Size (2015-2026)

8.2 Europe Pneumococcal Vaccines Key Players in North America (2015-2020)

8.3 Europe Pneumococcal Vaccines Market Size by Type (2015-2020)

8.4 Europe Pneumococcal Vaccines Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Pneumococcal Vaccines Market Size (2015-2026)

9.2 South Asia Pneumococcal Vaccines Key Players in North America (2015-2020)

9.3 South Asia Pneumococcal Vaccines Market Size by Type (2015-2020)

9.4 South Asia Pneumococcal Vaccines Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Pneumococcal Vaccines Market Size (2015-2026)

10.2 Southeast Asia Pneumococcal Vaccines Key Players in North America (2015-2020)

10.3 Southeast Asia Pneumococcal Vaccines Market Size by Type (2015-2020)

10.4 Southeast Asia Pneumococcal Vaccines Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Pneumococcal Vaccines Market Size (2015-2026)

11.2 Middle East Pneumococcal Vaccines Key Players in North America (2015-2020)

11.3 Middle East Pneumococcal Vaccines Market Size by Type (2015-2020)

11.4 Middle East Pneumococcal Vaccines Market Size by Application (2015-2020)

12. Africa

12.1 Africa Pneumococcal Vaccines Market Size (2015-2026)

12.2 Africa Pneumococcal Vaccines Key Players in North America (2015-2020)

12.3 Africa Pneumococcal Vaccines Market Size by Type (2015-2020)

12.4 Africa Pneumococcal Vaccines Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Pneumococcal Vaccines Market Size (2015-2026)

13.2 Oceania Pneumococcal Vaccines Key Players in North America (2015-2020)

13.3 Oceania Pneumococcal Vaccines Market Size by Type (2015-2020)

13.4 Oceania Pneumococcal Vaccines Market Size by Application (2015-2020)

14. South America

14.1 South America Pneumococcal Vaccines Market Size (2015-2026)

14.2 South America Pneumococcal Vaccines Key Players in North America (2015-2020)

14.3 South America Pneumococcal Vaccines Market Size by Type (2015-2020)

14.4 South America Pneumococcal Vaccines Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Pneumococcal Vaccines Market Size (2015-2026)

15.2 Rest of the World Pneumococcal Vaccines Key Players in North America (2015-2020)

15.3 Rest of the World Pneumococcal Vaccines Market Size by Type (2015-2020)

15.4 Rest of the World Pneumococcal Vaccines Market Size by Application (2015-2020)

16 Pneumococcal Vaccines Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Pneumococcal Vaccines Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Pneumococcal Vaccines Market?
Some of the finest and top-notch companies pioneering the Pneumococcal Vaccines Market are Pfizer, Sanofi, GSK, Merck, Eli Lilly, AstraZeneca, Abera, S K Chemicals, Beijing Minhai Biotechnology, Baxter, Biken, Celgene Corporation, Panacea Biotec, Serum Institute of India, Genentech, Genocea Biosciences, ImmunoBiology, Lupin, Nuron Biotech, Biogen, Valneva Austria, Sinovac.
How is the competition changing gears in the Pneumococcal Vaccines Industry?
Emerging markets will create new demands and put pressure on the industry to act quickly. Simultaneously, market players such as Pfizer, Sanofi, GSK, Merck, Eli Lilly, AstraZeneca, Abera, S K Chemicals, Beijing Minhai Biotechnology, Baxter, Biken, Celgene Corporation, Panacea Biotec, Serum Institute of India, Genentech, Genocea Biosciences, ImmunoBiology, Lupin, Nuron Biotech, Biogen, Valneva Austria, Sinovac will face challenges from the industry's increasing pace of consolidation, particularly in North America and Europe.
Where are the Pneumococcal Vaccines used?
The Pneumococcal Vaccines are employed in For Infants, For Children (2-10), For Person (10-64), For The Old (≥65).
What is the expected rate of growth in the Pneumococcal Vaccines Market?
From 2025 to 2030, the Pneumococcal Vaccines Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
What challenges does the Pneumococcal Vaccines Market face in the future?
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Pneumococcal Vaccines Market across the extensive corporate landscape.
What are the top priorities for the growth of the Pneumococcal Vaccines Market?
In this highly competitive and rapidly evolving Pneumococcal Vaccines Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.